新一代生物工艺研发与制造技术及高通量微小型生物反应器

焦鹏, 陈必强

中国工程科学 ›› 2016, Vol. 18 ›› Issue (4) : 44-50.

PDF(1838 KB)
PDF(1838 KB)
中国工程科学 ›› 2016, Vol. 18 ›› Issue (4) : 44-50. DOI: 10.15302/J-SSCAE-2016.04.007
专题研究

新一代生物工艺研发与制造技术及高通量微小型生物反应器

作者信息 +

Advanced Bioprocess Development and Manufacturing Technologies in High-Throughput Miniature Bioreactors

Author information +
History +

摘要

近些年,人们认识到快速反应时间对应对烈性传染病具有至关重要的作用,然而传统工艺和技术无法有效应对。以美国卫生部为代表的机构提出并开始践行新一代工艺研发与生物制造的技术平台,其目的是要极大缩短生物工艺研发和生产的周期,从而快速应对。精准医学的发展对医药研发与生产也提出了产品研发制备周期短、种类增加、数量减少的新要求,需要新一代的研发与生产技术。实现快速研发的核心设备是微小型生物反应器,新一代技术核心包括高通量筛选、高通量工艺研发,一次性技术,模块化及柔性化生产。新一代工艺研发与生物制造技术不仅关系到国家安全、人民生命健康,其作用及影响将辐射到整个生物加工制造领域,社会与经济价值巨大。

Abstract

In recent years, the importance of rapid response time to virulent infectious disease is widely recognized. However, the traditional technologies for bioprocess development and manufacturing will not succeed in winning this war. US healthcare companies and related organizations including US Department of Human Health and Service, proposed and started working on the next generation of technology platforms for advanced bioprocess development and manufacturing (ABDM).The development of ABDM is to significantly reduce the timeframe for bioprocess development and manufacturing, making it possible to promptly respond to outburst of pandemic influenza and prevent it from outspreading. Meanwhile, the development of precision medicine also presents new demands to the biopharmaceutical industry. With the demand of small-scale production and fast turn-around time of precision medicine, the duration of development and manufacturing needs to be accelerated significantly. At the same time, the number of sub-groups of the product would increase, and the batch sizes and amount of final product would decrease, as well. To satisfy the demands of small-scale production and fast turnaround time of ABDM, micro- and mini-bioreactor is the key equipment. The major technologies of ABDM include high throughput screening and process development based on micro- and mini-bioreactors, disposable technology, modular unit operations and flexible manufacturing. The development of ABDM will directly strengthen the National Security, improve the welfare of the people, and it also provides great social and economic values. The impact of this platform will radiate to the entire biomanufacture industry, and open a whole new era for the bioprocess development and bio-manufacturing.

关键词

新一代生物工艺研发与生物制造技术 / 烈性传染病 / 精准医学 / 微小型生物反应器 / 高通量技术 / 一次性技术

Keywords

advance bioprocess development and biomanufacturing / virulent infectious disease / precision medicine / miniature bioreactor / high throughput technology / disposable technology

引用本文

导出引用
焦鹏, 陈必强. 新一代生物工艺研发与制造技术及高通量微小型生物反应器. 中国工程科学. 2016, 18(4): 44-50 https://doi.org/10.15302/J-SSCAE-2016.04.007

参考文献

[1]
Taubenberger J K, Morens D M. 1918 Influenza: The mother of all pandemics [J]. Emerging Infectious Diseases, 2006, 12(1): 15–22.
[2]
H7N9禽流感最新消息: 广东15人死亡, 全国死亡人数超百人[N/OL]. 国际财经时报 , (2014-02-21)[2016-05-28]. http://www.ibtimes.com.cn/articles/35575/20140221/28192.htm.
[3]
Crosse M. HHS has funded flexible manufacturing activities for medical countermeasures, but it is too soon to assess their effect [J]. Gao Reports, 2014, 35(3): 53–54.
[4]
The U.S. Department of Health and Human Services. Advanced development of recombinant influenza vaccine products and man-ufacturing capabilities for pandemic preparedness [R]. Washington DC: Department of Health and Human Services, 2009.
[5]
The U.S. Department of Health and Human Services. Fiscal year 2015 work plan (mid-year update) [R/OL]. 2015[2016-05-28].
[6]
The Office of the Press Secretary of the White House. Fact sheet—Middle class economics: The president’s fiscal year 2016 budget (investing in American innovation) [EB/OL]. (2015-02-02) [2016-05-28].
[7]
Collins F S, Varmus H. A new initiative on precision medicine [J]. The New England Journal of Medicine, 2015, 372(9): 793–795.
[8]
Herbert M. Revolutionising the manufacture of precision medi-cines [EB/OL]. (2015-06-23) [2016-05-28].
[9]
Kaplan D. National science foundation (NSF) workshop report—Advanced biomanufacturing [C/OL].
[10]
焦鹏. 一种基于微小生物反应器的新型菌株复筛和前期发酵工艺开发平台[J]. 生物产业技术,2015,1(1):17-23.
[11]
Ngibuini M. Automated mini bioreactor technology for microbial and mammalian cell culture: Flexible strategy to optimize early process development of biologics and vaccines [J]. Bioprocess International, 2014(9): 20-25.
[12]
焦鹏. 国外一次性使用技术与一次性生物反应器在生物技术领域的应用现状[J]. 生物产业技术, 2013, 3(2): 46–50.
[13]
Galliher P M. Review of single use technologies in biomanufac-turing [R/OL]. 2007 [2016-05-28].
[14]
Wilson G. Evaluation of a Novel Micro-Bioreactor System for Cell Culture Optimisation [C]// Smith R, editor. Cell Technology for Cell Products. Proceedings of the 19th ESACT Meeting. Dor-drecht: Springer, 2005: 611.
[15]
Warr S R, Betts J P, Ahmad S, et al. Streamlined process develop-ment using the micro-24 bioreactor system [J]. BMC Proceedings, 2013, 7(suppl 6): 1–3.
[16]
Innovate UK. High throughput technologies (HTT) [EB/OL]. [2016-05-28].
基金
中国工程院重大咨询项目“‘十三五’战略性新兴产业培育与发展规划研究”(2014-ZD-7)
PDF(1838 KB)

Accesses

Citation

Detail

段落导航
相关文章

/